PI3K inhibitors as potential therapeutics for autoimmune disease
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference35 articles.
1. Autoimmunity in human primary immunodeficiency diseases;Arkwright;Blood,2002
2. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States;Walsh;Am. J. Public Health,2000
3. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts;Van der Woude;Arthritis Rheum.,2009
4. A cost-effectiveness of biological therapeutic sequences for rheumatoid arthritis in the UK;Emery;Value Health,2009
5. The emerging mechanisms of isoform-specific PI3K signalling;Vanhaesebroeck;Nat. Rev. Mol. Cell Biol.,2010
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of Novel Azaindoles as Potent and Selective PI3Kδ Inhibitors for Treatment of Multiple Sclerosis;Journal of Medicinal Chemistry;2024-05-16
2. FDA approved fused-pyrimidines as potential PI3K inhibitors: a computational repurposing approach;Journal of Biomolecular Structure and Dynamics;2023-11
3. Advances in the Discovery of Novel Inhaled PI3Kδ Inhibitors for the Treatment of Asthma;Current Medicinal Chemistry;2023-05
4. Identification of new candidate drugs for primary Sjögren’s syndrome using a drug repurposing transcriptomic approach;Rheumatology;2023-03-03
5. A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity;International Journal of Molecular Sciences;2022-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3